Mathew MacCumber (Rush University Medical Centre, Chicago) provides seom updates from the DCRC Retina Protocls including the findings from Protocol V.
1. What have been the most important developments in DME in the last year?
2. What is the current standard of care for patients with centre-involved DME with good vision?
3. Could you tell us a little about the Protocol V trial and its findings?
4. What have been the most interesting findings from the other DRCR Retina Network Protocols ongoing trials?
Disclaimer: The thoughts and opinions expressed in this video are those of Mathew MacCumber and don’t necessarily reflect though of the DRCR Retina Network.
Support: No funding was received in the production of this video.
Share this Video
Related Videos In Retina/Vitreous
Tommaso Rossi, EURETINA 2020 – Novel Instrument for Internal Limiting Membrane
We were delighted to catch up with Prof. Tommaso Rossi, who talked us through his presentation at EURETINA 2020 concerning a novel instrument for internal limiting membrane, amniotic and retinal flap manipulation. Questions What is the rationale for the use of amniotic membrane grafts in vitreoretinal surgery, and in what ophthalmic indications are they used? […]
Peter Stalmans, EURETINA 2020 – End-stage Retinitis Pigmentosa Patients Implanted with 3D–neural Interface Retinal Prosthesis
Prof. Peter Stalmans (University Hospitals, Leuven, Belgium) talked us through his presentation at EURETINA on first reported clinical results from end-stage retinitis pigmentosa patients implanted with an innovative 3D neural interface retinal prosthesis. Questions Could you give us an overview of advances in retinal prosthesis approaches in the treatment of advanced retinitis pigmentosa […]
Jost Jonas, EURETINA 2019 – Myopia: Epidemiology, Histology & Clinics
It was fantastic to meet up with Jost Jonas (Ruprecht-Karls University) to discuss the Keynote Lecture ‘Myopia: Epidemiology, Histology & Clinics’ he presented at this year’s meeting. Support: No funding was received in the production of this video. Disclosures: Jost Jonas has nothing to disclose in relation to this video.
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!